Robert Iannone
EVP, Global Head of R&D & CMO · Jazz Pharmaceuticals plc
- 2025
- Aug 31, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Iannone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $27.78M in JAZZ purchases and sales in the last 12 months
- Neena M. Patil - $11.50M in JAZZ purchases and sales in the last 12 months
- Patricia Carr - $1.66M in JAZZ purchases and sales in the last 12 months
- Rick E. Winningham - $1.66M in JAZZ purchases and sales in the last 12 months
- Samantha Pearce - $1.63M in JAZZ purchases and sales in the last 12 months
- Heather Ann McSharry - $1.09M in JAZZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Iannone?
Robert Iannone is a corporate insider, tracked as EVP, Global Head of R&D & CMO of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert Iannone submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Robert Iannone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($20.41M) across all tracked filings.
